News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
469,764 Results
Type
Article (17307)
Company Profile (128)
Press Release (452329)
Section
Business (149435)
Career Advice (826)
Deals (25511)
Drug Delivery (31)
Drug Development (41940)
Employer Resources (73)
FDA (10333)
Job Trends (9480)
News (229660)
Policy (16585)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1402)
Accelerated approval (2)
Adcomms (3)
Allergies (42)
Alliances (39517)
ALS (36)
Alzheimer's disease (624)
Antibody-drug conjugate (ADC) (67)
Approvals (10361)
Artificial intelligence (233)
Autoimmune disease (3)
Automation (11)
Bankruptcy (187)
Best Places to Work (7697)
BIOSECURE Act (6)
Biosimilars (19)
Biotechnology (100)
Bladder cancer (29)
Brain cancer (17)
Breast cancer (135)
Cancer (1151)
Cardiovascular disease (64)
Career advice (721)
Career pathing (9)
CAR-T (99)
Cell therapy (288)
Cervical cancer (10)
Clinical research (33756)
Collaboration (618)
Compensation (222)
Complete response letters (4)
COVID-19 (1240)
CRISPR (35)
C-suite (165)
Cystic fibrosis (60)
Data (1178)
Decentralized trials (1)
Denatured (18)
Depression (19)
Diabetes (111)
Diagnostics (5352)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (19)
Drug discovery (79)
Drug pricing (17)
Drug shortages (4)
Duchenne muscular dystrophy (23)
Earnings (59595)
Editorial (4)
Employer branding (11)
Employer resources (66)
Events (72733)
Executive appointments (495)
FDA (11016)
Featured Employer (29)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (505)
Gene editing (83)
Generative AI (23)
Gene therapy (174)
GLP-1 (277)
Government (1465)
Grass and pollen (2)
Guidances (28)
Healthcare (12238)
Huntington's disease (6)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (13)
Infectious disease (1314)
Inflammatory bowel disease (75)
Inflation Reduction Act (3)
Influenza (32)
Intellectual property (63)
Interviews (98)
IPO (11915)
IRA (8)
Job creations (2099)
Job search strategy (647)
Kidney cancer (6)
Labor market (11)
Layoffs (187)
Leadership (6)
Legal (4002)
Liver cancer (38)
Lung cancer (143)
Lymphoma (72)
Machine learning (2)
Management (25)
Manufacturing (175)
MASH (31)
Medical device (12139)
Medtech (12144)
Mergers & acquisitions (13976)
Metabolic disorders (263)
Multiple sclerosis (28)
NASH (7)
Neurodegenerative disease (30)
Neuropsychiatric disorders (4)
Neuroscience (855)
NextGen: Class of 2025 (4303)
Non-profit (1953)
Northern California (1581)
Now hiring (9)
Obesity (116)
Opinion (98)
Ovarian cancer (50)
Pain (50)
Pancreatic cancer (41)
Parkinson's disease (70)
Partnered (12)
Patents (139)
Patient recruitment (59)
Peanut (26)
People (42891)
Pharmaceutical (21)
Pharmacy benefit managers (1)
Phase I (11497)
Phase II (14964)
Phase III (10550)
Pipeline (776)
Podcasts (37)
Policy (27)
Postmarket research (990)
Preclinical (4957)
Press Release (72)
Prostate cancer (51)
Psychedelics (7)
Radiopharmaceuticals (195)
Rare diseases (176)
Real estate (4150)
Recruiting (27)
Regulatory (12025)
Reports (21)
Research institute (1387)
Resumes & cover letters (124)
Rett syndrome (3)
RNA editing (2)
RSV (21)
Schizophrenia (26)
Series A (88)
Series B (56)
Service/supplier (7)
Sickle cell disease (23)
Southern California (1448)
Special edition (2)
Spinal muscular atrophy (69)
Sponsored (14)
Startups (2812)
State (2)
Stomach cancer (3)
Supply chain (28)
The Weekly (18)
United States (14168)
Vaccines (326)
Venture capitalists (21)
Webinars (10)
Weight loss (47)
Women's health (17)
Worklife (2)
Date
Today (69)
Last 7 days (438)
Last 30 days (1800)
Last 365 days (22518)
2025 (5464)
2024 (23912)
2023 (28221)
2022 (37973)
2021 (40237)
2020 (38228)
2019 (31602)
2018 (23944)
2017 (23273)
2016 (22000)
2015 (26342)
2014 (19973)
2013 (16604)
2012 (17926)
2011 (18541)
2010 (17313)
Location
Africa (425)
Alabama (45)
Alaska (7)
Arizona (140)
Arkansas (11)
Asia (28285)
Australia (4785)
California (3708)
Canada (1314)
China (260)
Colorado (187)
Connecticut (178)
Delaware (56)
Europe (60227)
Florida (556)
Georgia (143)
Idaho (43)
Illinois (319)
India (15)
Indiana (180)
Iowa (5)
Japan (114)
Kansas (85)
Kentucky (13)
Louisiana (6)
Maine (57)
Maryland (502)
Massachusetts (2700)
Michigan (195)
Minnesota (298)
Mississippi (2)
Missouri (67)
Montana (28)
Nebraska (20)
Nevada (37)
New Hampshire (66)
New Jersey (1054)
New Mexico (19)
New York (1023)
North Carolina (659)
North Dakota (7)
Northern California (1581)
Ohio (130)
Oklahoma (12)
Oregon (20)
Pennsylvania (733)
Puerto Rico (7)
Rhode Island (23)
South America (658)
South Carolina (16)
South Dakota (1)
Southern California (1448)
Tennessee (67)
Texas (550)
Utah (110)
Virginia (77)
Washington D.C. (17)
Washington State (376)
West Virginia (3)
Wisconsin (42)
469,764 Results for "biospecifics technologies corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals
February 27, 2025
·
3 min read
Deals
NanoString Technologies to Be Acquired by Bruker Corporation
NanoString Technologies, Inc. (“NanoString” or “the Company”) today announced that substantially all of its assets will be acquired by Bruker Corporation (“Bruker”), a global life science analytical instrument company, for approximately $392.6 million in cash consideration, plus the assumption of certain liabilities.
April 17, 2024
·
6 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Business
GT Medical Technologies, Inc. and Theragenics Corporation Forge Distribution Partnership for Cesium-131
GT Medical Technologies, Inc. today announced it has entered into a strategic distribution partnership with Theragenics Corporation® (Theragenics), a global leader in minimally invasive brachytherapy.
May 1, 2024
·
4 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
BioForest
Simulab Corporation Announces New Technology in Medical Simulation With SimuSkin(TM)
Simulab Corporation proudly unveils its latest technology - SimuSkin.
January 18, 2024
·
2 min read
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2024 and Raises Full Year Guidance
Sensient Technologies Corporation, a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, reported financial results for the first quarter ended March 31, 2024.
April 26, 2024
·
16 min read
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
Daxor Corporation today announces it will be exhibiting at the Technology and Heart Failure Therapeutics Conference (THT), which brings together the world’s leading experts in heart failure innovations at the Westin Boston Seaport in Boston, Massachusetts March 4-6, 2024.
February 26, 2024
·
3 min read
Press Releases
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
March 26, 2025
·
17 min read
Press Releases
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
March 4, 2025
·
13 min read
1 of 46,977
Next
